EcoDrugPlus

Ribosomal Protein L18a

Ensembl ID : ENSLACG00000018235
Gene Symbol: RPL18A
4 Cross references
373 Possible Orthologues:

Ribosomal Protein L21

Ensembl ID : ENSLACG00000012678
Gene Symbol: RPL21
4 Cross references
784 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSLACG00000016388
Gene Symbol: RPL22
4 Cross references
6 Possible Orthologues:

Ribosomal Protein L23a

Ensembl ID : ENSLACG00000007868
Gene Symbol: RPL23A
2 Cross references
150 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSLACG00000004303
Gene Symbol: RPL24
4 Cross references
322 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSLACG00000007797
Gene Symbol: RPL27
4 Cross references
370 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSLACG00000016622
Gene Symbol: RPL27A
4 Cross references
520 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSLACG00000011783
Gene Symbol: RPL28
2 Cross references
285 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSLACG00000018031
Gene Symbol: RPL29
1 Cross references
495 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSLACG00000006276
Gene Symbol: RPL3
4 Cross references
287 Possible Orthologues:

Ribosomal Protein L31

Ensembl ID : ENSLACG00000013603
Gene Symbol: RPL31
4 Cross references
651 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSLACG00000013692
Gene Symbol: RPL32
4 Cross references
236 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).